REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 161 filers reported holding REVANCE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.13 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $250,123 | -47.9% | 97,324 | -0.2% | 0.00% | -100.0% |
Q1 2024 | $479,666 | -38.6% | 97,493 | +9.8% | 0.00% | 0.0% |
Q4 2023 | $780,772 | -26.5% | 88,825 | -4.2% | 0.00% | -50.0% |
Q3 2023 | $1,062,982 | -58.6% | 92,675 | -8.7% | 0.00% | -50.0% |
Q2 2023 | $2,569,826 | -22.0% | 101,534 | -0.8% | 0.00% | -20.0% |
Q1 2023 | $3,295,598 | +73.8% | 102,316 | -0.4% | 0.01% | +66.7% |
Q4 2022 | $1,896,728 | -28.2% | 102,748 | +5.0% | 0.00% | -25.0% |
Q3 2022 | $2,642,000 | +116.7% | 97,856 | +10.9% | 0.00% | +100.0% |
Q2 2022 | $1,219,000 | -29.4% | 88,214 | -0.4% | 0.00% | 0.0% |
Q1 2022 | $1,727,000 | +10.2% | 88,547 | -7.8% | 0.00% | 0.0% |
Q4 2021 | $1,567,000 | -39.9% | 96,025 | +2.7% | 0.00% | -33.3% |
Q3 2021 | $2,606,000 | -9.2% | 93,535 | -3.4% | 0.00% | -25.0% |
Q2 2021 | $2,869,000 | +8.2% | 96,799 | +2.0% | 0.00% | 0.0% |
Q1 2021 | $2,652,000 | -1.8% | 94,893 | -0.4% | 0.00% | 0.0% |
Q4 2020 | $2,700,000 | +12.8% | 95,261 | +0.0% | 0.00% | 0.0% |
Q3 2020 | $2,394,000 | +14.5% | 95,235 | +11.2% | 0.00% | 0.0% |
Q2 2020 | $2,091,000 | +80.1% | 85,625 | +9.1% | 0.00% | +33.3% |
Q1 2020 | $1,161,000 | +4.2% | 78,450 | +14.3% | 0.00% | +50.0% |
Q4 2019 | $1,114,000 | +24.9% | 68,618 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $892,000 | +1.5% | 68,618 | +1.2% | 0.00% | 0.0% |
Q2 2019 | $879,000 | -5.9% | 67,799 | +14.4% | 0.00% | 0.0% |
Q1 2019 | $934,000 | -9.7% | 59,257 | +15.4% | 0.00% | 0.0% |
Q4 2018 | $1,034,000 | -17.1% | 51,364 | +2.3% | 0.00% | 0.0% |
Q3 2018 | $1,248,000 | -9.5% | 50,206 | -0.0% | 0.00% | -33.3% |
Q2 2018 | $1,379,000 | +9.3% | 50,223 | +22.5% | 0.00% | 0.0% |
Q1 2018 | $1,262,000 | -2.3% | 40,990 | +13.4% | 0.00% | 0.0% |
Q4 2017 | $1,292,000 | +28.4% | 36,132 | -1.1% | 0.00% | +50.0% |
Q3 2017 | $1,006,000 | -4.2% | 36,522 | -8.2% | 0.00% | 0.0% |
Q2 2017 | $1,050,000 | +25.3% | 39,770 | -1.2% | 0.00% | 0.0% |
Q1 2017 | $838,000 | -3.8% | 40,270 | -4.3% | 0.00% | 0.0% |
Q4 2016 | $871,000 | +24.3% | 42,070 | -2.8% | 0.00% | +100.0% |
Q3 2016 | $701,000 | +20.2% | 43,270 | +0.9% | 0.00% | 0.0% |
Q2 2016 | $583,000 | -13.9% | 42,870 | +10.5% | 0.00% | 0.0% |
Q1 2016 | $677,000 | -41.6% | 38,794 | +14.2% | 0.00% | -66.7% |
Q4 2015 | $1,160,000 | +37.0% | 33,966 | +19.3% | 0.00% | +50.0% |
Q3 2015 | $847,000 | -7.3% | 28,474 | -0.3% | 0.00% | 0.0% |
Q2 2015 | $914,000 | +177.0% | 28,574 | +79.3% | 0.00% | +100.0% |
Q1 2015 | $330,000 | +22.2% | 15,940 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $270,000 | -12.1% | 15,940 | +0.4% | 0.00% | 0.0% |
Q3 2014 | $307,000 | -28.3% | 15,872 | +26.0% | 0.00% | 0.0% |
Q2 2014 | $428,000 | +7.8% | 12,600 | 0.0% | 0.00% | 0.0% |
Q1 2014 | $397,000 | – | 12,600 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |